Central diabetes insipidus
ICD-10 E23.2 · ICD-11 5A61.5

Treatment of Central Diabetes Insipidus with Osmoreceptor Damage and Absent Osmoregulated Thirst

Clinical scenario

This protocol addresses central diabetes insipidus in which the underlying lesion involves the osmoreceptors in the anterior hypothalamus, causing loss of osmoregulated thirst. Because the normal thirst mechanism is absent, patients cannot self-regulate fluid intake in response to rising plasma osmolality — removing the key physiological safeguard against both dehydration and fluid overload.

Defining feature of this sub-population

The hallmark of this presentation is absent osmoregulated thirst: the anterior hypothalamic osmoreceptors are damaged alongside the AVP-secreting system, eliminating the thirst response that would otherwise signal fluid need. This distinguishes adipsic central diabetes insipidus from the typical form and substantially raises the risk of undetected hyper- or hyponatraemia.

Treatment approach (partial overview)

Management combines dDAVP to regulate urinary output with a structured, fixed daily fluid intake and daily self-weighing to detect early fluid imbalance. Prophylactic anticoagulation is also incorporated as part of this protocol given specific risks reported in this population.

Complete regimen details — including specific doses, fluid volumes, individualised adjustments, and the full clinical algorithm — are available in the structured protocol below.
Clinical goals

The primary aim is the establishment of a stable eunatremic body weight together with a stable plasma sodium concentration — the two key markers confirming safe, sustained fluid balance in this setting.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1210/clinem/dgac381

View source ↗